Additional studies in humans revealed no difference between the presence of AAV in multiple tumor tissues when compared to the adjacent non-tumor tissue in more than 400 cancer patients [68], and functional p53 has been shown to reduce AAV integration events [69]. The gene discussed is TP53; the disease is cancer.